TY - JOUR AB - Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that certain of the cell invasion and migration assay data shown in Figs. 2C and 5C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Experimental and Therapeutic Medicine, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Experimental and Therapeutic Medicine 18: 1449‑1457, 2019; DOI: 10.3892/etm.2019.7676] AD - Department of Thoracic Surgery, Affiliated Nanhai Hospital, Southern Medical University (People's Hospital of Nanhai District), Foshan, Guangdong 528000, P.R. China AU - Zhou,Guohua AU - Xie,Jinglian AU - Gao,Zikun AU - Yao,Weishen DA - 2022/11/01 DO - 10.3892/etm.2022.11588 IS - 5 JO - Exp Ther Med KW - non‑small cell lung cancer microRNA‑877 insulin‑like growth factor 1 receptor proliferation invasion PY - 2022 SN - 1792-0981 1792-1015 SP - 651 ST - [Retracted] MicroRNA‑877 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting IGF‑1R T2 - Experimental and Therapeutic Medicine TI - [Retracted] MicroRNA‑877 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting IGF‑1R UR - https://doi.org/10.3892/etm.2022.11588 VL - 24 ER -